Chenqi Xu completed his PhD training in protein chemistry with Dr. Chengwu Chi in 2004 at Chinese Academy of Sciences. A part of his PhD work was done in University of Leuven and University of Hasselt in Belgium. He then received postdoctoral training in immunology with Dr. Kai Wucherpfennig at Dana Farber Cancer Institute, Harvard Medical School. In 2009, he moved back to China to start his independent program focusing on T cell signaling and metabolism. The Xu lab has developed cutting-edge biochemical and biophysical tools to study immunoreceptor signaling and translates the basic knowledge to the development of engineered T cell therapy. In addition, he is interested in the fundamental functions of membrane lipids in T cell biology and have demonstrated the application potential of cholesterol-based immunotherapy. His works have been published in Nature, Cell and other prestigious journals, and selected as Top 10 Science Breakthroughs in China. He have been recognized with prestigious awards, including Shanghai Natural Science Award, Science and Technology Award for Chinese Youth, Xplorer Prize, and Young Investigator Award of Chinese Biological Investigators Society.